Natural polyphenol-based nanoparticles for the treatment of iron-overload disease

J Control Release. 2023 Apr:356:84-92. doi: 10.1016/j.jconrel.2023.02.027. Epub 2023 Mar 1.

Abstract

Iron-overload diseases are characterized by a variety of symptoms resulting from excessive iron stores, oxidative stress and consequent end-organ damage. Deferoxamine (DFO) is an iron-chelator that can protect tissues from iron-induced damage. However, its application is limited due to its low stability and weak free radical scavenging ability. Herein, natural polyphenols have been employed to enhance the protective efficacy of DFO through the construction of supramolecular dynamic amphiphiles, which self-assemble into spherical nanoparticles with excellent scavenging capacity against both iron (III) and reactive oxygen species (ROS). This class of natural polyphenols-assisted nanoparticles was found to exhibit enhanced protective efficacy both in vitro in an iron-overload cell model and in vivo in an intracerebral hemorrhage model. This strategy of constructing natural polyphenols- assisted nanoparticles could benefit the treatment of iron-overload related diseases with excessive accumulation of toxic or harmful substances.

Keywords: Deferoxamine; Nanoparticle; Natural polyphenols; iron-overload protection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Deferoxamine / pharmacology
  • Deferoxamine / therapeutic use
  • Humans
  • Iron
  • Iron Chelating Agents / therapeutic use
  • Iron Overload*
  • Nanoparticles*
  • Polyphenols / therapeutic use

Substances

  • Deferoxamine
  • Iron Chelating Agents
  • Polyphenols
  • Iron